These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19124052)

  • 21. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2).
    Doyle L; Ross DD
    Oncogene; 2003 Oct; 22(47):7340-58. PubMed ID: 14576842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro methods suitable for the prediction of drug and ABC transporter, especially ABCG2 interactions].
    Pál A; Kis E; Méhn D; Glavinas H; Nagy T; Mészaros P; Báthori G; Krajcsi P; Falkay G
    Acta Pharm Hung; 2007; 77(4):205-16. PubMed ID: 18290540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functions of the breast cancer resistance protein (BCRP/ABCG2) in chemotherapy.
    Noguchi K; Katayama K; Mitsuhashi J; Sugimoto Y
    Adv Drug Deliv Rev; 2009 Jan; 61(1):26-33. PubMed ID: 19111841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ins and outs of the ABCG2 multidrug transporter: an update on in vitro functional assays.
    Hegedus C; Szakács G; Homolya L; Orbán TI; Telbisz A; Jani M; Sarkadi B
    Adv Drug Deliv Rev; 2009 Jan; 61(1):47-56. PubMed ID: 19135105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urate exporter gene ABCG 2/BCRP and gout risk].
    Takada T; Matsuo H
    Seikagaku; 2011 Dec; 83(12):1131-5. PubMed ID: 22352045
    [No Abstract]   [Full Text] [Related]  

  • 26. Role of the breast cancer resistance protein (ABCG2) in drug transport.
    Mao Q; Unadkat JD
    AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2.
    Pál A; Méhn D; Molnár E; Gedey S; Mészáros P; Nagy T; Glavinas H; Janáky T; von Richter O; Báthori G; Szente L; Krajcsi P
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1085-94. PubMed ID: 17347325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allocrite Sensing and Binding by the Breast Cancer Resistance Protein (ABCG2) and P-Glycoprotein (ABCB1).
    Xu Y; Egido E; Li-Blatter X; Müller R; Merino G; Bernèche S; Seelig A
    Biochemistry; 2015 Oct; 54(40):6195-206. PubMed ID: 26381710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.
    Shi Z; Peng XX; Kim IW; Shukla S; Si QS; Robey RW; Bates SE; Shen T; Ashby CR; Fu LW; Ambudkar SV; Chen ZS
    Cancer Res; 2007 Nov; 67(22):11012-20. PubMed ID: 18006847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A novel marker of multiple drug resistance BCRP].
    Bogush TA; Pokataev IA; Timofeeva NV; Ozherel'ev AS
    Antibiot Khimioter; 2003; 48(6):33-41. PubMed ID: 14558417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Drug resistance mediated by ABC transporters].
    Yoshikawa M; Ito A; Ishikawa T; Ikegami Y
    Gan To Kagaku Ryoho; 2004 Jan; 31(1):1-6. PubMed ID: 14750312
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ABC transporters do not contribute to extracellular translocation of hyaluronan in human breast cancer in vitro.
    Thomas NK; Brown TJ
    Exp Cell Res; 2010 Apr; 316(7):1241-53. PubMed ID: 20060827
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Walker A mutation (K86M) on oligomerization and surface targeting of the multidrug resistance transporter ABCG2.
    Henriksen U; Gether U; Litman T
    J Cell Sci; 2005 Apr; 118(Pt 7):1417-26. PubMed ID: 15769853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design of inhibitors of BCRP/ABCG2.
    Juvale K; Wiese M
    Future Med Chem; 2015 Aug; 7(12):1521-7. PubMed ID: 26293476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of the human ABCG2 multidrug transporter and its variants in cancer therapy and toxicology.
    Cervenak J; Andrikovics H; Ozvegy-Laczka C; Tordai A; Német K; Váradi A; Sarkadi B
    Cancer Lett; 2006 Mar; 234(1):62-72. PubMed ID: 16337740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure, function, expression, genomic organization, and single nucleotide polymorphisms of human ABCB1 (MDR1), ABCC (MRP), and ABCG2 (BCRP) efflux transporters.
    Choudhuri S; Klaassen CD
    Int J Toxicol; 2006; 25(4):231-59. PubMed ID: 16815813
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.
    Do TM; Noel-Hudson MS; Ribes S; Besengez C; Smirnova M; Cisternino S; Buyse M; Calon F; Chimini G; Chacun H; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2012; 30(1):155-66. PubMed ID: 22391220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of basic residues within or near the predicted transmembrane helix 2 of the human breast cancer resistance protein in drug transport.
    Cai X; Bikadi Z; Ni Z; Lee EW; Wang H; Rosenberg MF; Mao Q
    J Pharmacol Exp Ther; 2010 Jun; 333(3):670-81. PubMed ID: 20203106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiological and pharmacological roles of ABCG2 (BCRP): recent findings in Abcg2 knockout mice.
    Vlaming ML; Lagas JS; Schinkel AH
    Adv Drug Deliv Rev; 2009 Jan; 61(1):14-25. PubMed ID: 19118589
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABC transporters, neural stem cells and neurogenesis--a different perspective.
    Lin T; Islam O; Heese K
    Cell Res; 2006 Nov; 16(11):857-71. PubMed ID: 17088897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.